Carregant...
Inflammatory Cytokine Profile in Crohn’s Disease Non-Responders to Optimal Anti-Tumor Necrosis Factor Therapy
BACKGROUND: A significant number of patients receiving therapy with anti-tumor necrosis factor (TNF) agents for Crohn’s disease (CD) experience primary or secondary non-response. The aim of this study was to assess if patients with non-response to anti-TNF agents have increased expression of alterna...
Guardat en:
| Publicat a: | J Clin Gastroenterol |
|---|---|
| Autors principals: | , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6127004/ https://ncbi.nlm.nih.gov/pubmed/29517712 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MCG.0000000000001002 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|